Stenocare A/S (CPH:STENO)

Market Cap	57.23M +258.1%
Revenue (ttm)	5.67M +184.0%
Net Income	-24.58M
EPS	-0.74
Shares Out	43.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	147,037
Average Volume	155,015
Open	1.320
Previous Close	1.325
Day's Range	1.320 - 1.475
52-Week Range	0.194 - 2.800
Beta	0.29
RSI	43.83
Earnings Date	Feb 27, 2026

About Stenocare

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 8
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: STENO

Financial Performance

In 2024, Stenocare's revenue was 2.23 million, a decrease of -40.60% compared to the previous year's 3.76 million. Losses were -34.49 million, 96.3% more than in 2023.